PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets

Eur Urol. 2017 Jun;71(6):863-865. doi: 10.1016/j.eururo.2017.01.049. Epub 2017 Feb 14.

Authors

Miriam Marqués¹, Francisco X Real²

Affiliations

¹ Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, Spanish National Cancer Research Centre, Madrid, Spain. Electronic address: mmarques@cnio.es.
² Epithelial Carcinogenesis Group, Cancer Cell Biology Programme, Spanish National Cancer Research Centre, Madrid, Spain; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain. Electronic address: preal@cnio.es.

PMID: 28214032
DOI: 10.1016/j.eururo.2017.01.049

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Receptor, Fibroblast Growth Factor, Type 3
Receptors, Fibroblast Growth Factor*
Urinary Bladder Neoplasms*

Substances

Receptors, Fibroblast Growth Factor
Receptor, Fibroblast Growth Factor, Type 3